Back to Search Start Over

Glucocorticoids ameliorate cardiorenal syndrome through the NPR1/SGK1 pathway in natriuretic peptide receptor A‑heterozygous mice.

Authors :
Huang YM
Li TX
Li SY
Zhu XR
Li Y
Liu DY
Li WM
Yang LQ
Liu KS
Liu C
Source :
Experimental and therapeutic medicine [Exp Ther Med] 2023 Jun 22; Vol. 26 (2), pp. 374. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).
Publication Year :
2023

Abstract

Natriuretic peptides, which are produced by the heart, bind to natriuretic peptide receptor A (NPR1 encoded by natriuretic peptide receptor 1 gene) and cause vasodilation and natriuresis. Thus, they serve an important role in regulating blood pressure. In the present study, microinjection of CRISPR associated protein 9/single guide RNA into fertilized C57BL/6N mouse eggs was performed to generate filial generation zero (F0) Npr1 knockout homozygous mice (Npr1 <superscript>-/-</superscript> ). F0 mice mated with wild-type (WT) mice to obtain F1 Npr1 knockout heterozygous mice with stable heredity (Npr1 <superscript>+/-</superscript> ). F1 self-hybridization was used to expand the population of heterozygous mice (Npr1 <superscript>+/-</superscript> ). The present study performed echocardiography to investigate the impact of NPR1 gene knockdown on cardiac function. Compared with those in the WT group (C57BL/6N male mice), the left ventricular ejection fraction, myocardial contractility and renal sodium and potassium excretion and creatinine-clearance rates were decreased, indicating that Npr1 knockdown induced cardiac and renal dysfunction. In addition, expression of serum glucocorticoid-regulated kinase 1 (SGK1) increased significantly compared with that in WT mice. However, glucocorticoids (dexamethasone) upregulated NPR1 and inhibited SGK1 and alleviated cardiac and renal dysfunction caused by Npr1 gene heterozygosity. SGK1 inhibitor GSK650394 ameliorate cardiorenal syndrome by suppressing SGK1. Briefly, glucocorticoids inhibited SGK1 by upregulating NPR1, thereby ameliorating cardiorenal impairment caused by Npr1 gene heterozygosity. The present findings provided novel insight into the understanding of cardiorenal syndrome and suggested that glucocorticoids targeting the NPR1/SGK1 pathway may be a potential therapeutic target to treat cardiorenal syndrome.<br />Competing Interests: The authors declare that they have no competing interests.<br /> (Copyright: © Huang et al.)

Details

Language :
English
ISSN :
1792-1015
Volume :
26
Issue :
2
Database :
MEDLINE
Journal :
Experimental and therapeutic medicine
Publication Type :
Academic Journal
Accession number :
37415837
Full Text :
https://doi.org/10.3892/etm.2023.12073